Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Depression, constipation, and UTIs may be early signs of multiple sclerosis

In some diseases, the underlying processes can start years before a diagnosis is made. A new study finds that people who later develop multiple sclerosis (MS) are more likely to have conditions like depression, constipation and urinary tract infections five years before their MS diagnosis than people who do not develop MS.

5 Dec 2023

New report exposes gaps in dementia care services across Europe

In a report launched today at a lunch debate hosted by Deirdre Clune MEP (Ireland), Alzheimer Europe highlighted the continuing inequalities in access to dementia care and treatment across Europe.

5 Dec 2023

Targeting Alzheimer's with cell-specific genetics

Developing treatments for Alzheimer's disease (AD) is difficult because complex underlying mechanisms drive different types of cells that may contribute to the disorder.

5 Dec 2023

Study may shed light on new ways to counteract the effects of high blood pressure on cognition

A study supported by the National Institutes of Health suggests that the response of immune system cells inside the protective covering surrounding the brain may contribute to the cognitive decline that can occur in a person with chronic high blood pressure.

5 Dec 2023

The association between hypertensive disorders of pregnancy and subsequent risk of dementia

Researchers examined the link between hypertensive disorders of pregnancy (HDP) and the increased risk of dementia, utilizing a systematic review and meta-analysis approach to cohort studies.

5 Dec 2023

Researchers evaluate possible mitochondrial factors in Alzheimer's pathogenesis

A group of authors critically evaluated and interpreted the evidence linking mitochondrial dysfunction and metabolic changes to the pathogenesis of Alzheimer's disease (AD).

5 Dec 2023

Diets play a major role in reducing the risk of Alzheimer's disease

In a detailed study, Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding published in the Journal of Alzheimer's Disease, we can finally see which diets are helpful in reducing the risk of developing Alzheimer's disease.

4 Dec 2023

New insights into the interplay between prions and TDP-43 in neurodegenerative pathology

Neurodegenerative diseases are characterized by the deposition of clumped proteins in the brain and progressive neuronal cell death.

4 Dec 2023

Neuroimaging and network modeling tools shed light on Alzheimer's disease in animal models

Indiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools - previously developed to analyze brains of patients in the clinic - to investigate Alzheimer's disease progression in preclinical animal models.

4 Dec 2023

Study evaluates personality predictors of dementia diagnosis and neuropathology

Personality predictors of dementia diagnosis and neuropathological burden.

1 Dec 2023

Study finds top three classes of medications more effective than ibuprofen for treating migraine attacks

For many people with migraine, it can be difficult to find a treatment that is effective and reliable, and information on how medications compare to one another is lacking.

29 Nov 2023

Deep brain, multipurpose fiber could revolutionize Alzheimer's research

Every 65 seconds, someone in the United States develops Alzheimer's disease, a devastating form of dementia that affects 6.2 million Americans.

29 Nov 2023

Study finds link between early coronary heart disease and dementia

Adults diagnosed with coronary heart disease, especially before the age of 45, may be at increased risk of developing dementia, Alzheimer's disease and vascular dementia later in life, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

29 Nov 2023

Study uncovers mechanisms underlying microglia-driven neuroinflammation in Alzheimer's disease

A study by Brigham investigators revealed how genetic changes in certain types of brain cells may contribute to the inflammatory response seen in Alzheimer's disease.

28 Nov 2023

Personalized lifestyle changes delay memory loss in older adults at risk for Alzheimer's

As more medications move toward federal approval for Alzheimer's disease, a new study led by researchers at UC San Francisco and Kaiser Permanente Washington has found that personalized health and lifestyle changes can delay or even prevent memory loss for higher-risk older adults.

28 Nov 2023

Dementia patients often receive different treatment after hospital transfer, study finds

It is common for individuals seeking medical care for symptoms of concern to go to the nearest hospital. Physicians there may determine the facility cannot provide the care they believe the patient needs and recommend transfer to another hospital offering a higher level of care or specialized services.

28 Nov 2023

Immune receptor protein linked to healthy aging and lifespan in mice

Life expectancy and healthy aging in mice can be determined by a protein present in some cells of the immune system, according to a study published in the journal Cell Reports.

28 Nov 2023

Study shows link between personal wealth and health care costs in people with Alzheimer’s disease

Finland has a strong public health care system; nevertheless, personal wealth is associated with the costs of hospital care and medication in people with Alzheimer's disease.

28 Nov 2023

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

Talk to focus on the spinout journey from drug repurposing to clinical trials for diagnosing and treating Alzheimer’s Disease.

28 Nov 2023

Brain inflammation linked to neuropsychiatric symptoms in Alzheimer's

Common neuropsychiatric symptoms that doctors see in Alzheimer's disease patients originate from brain inflammation rather than amyloid and tau proteins, report University of Pittsburgh School of Medicine researchers today in JAMA Network Open.

27 Nov 2023

Alzheimer's Disease News and Research

Further Reading

Depression, constipation, and UTIs may be early signs of multiple sclerosis

New report exposes gaps in dementia care services across Europe

Targeting Alzheimer's with cell-specific genetics

Study may shed light on new ways to counteract the effects of high blood pressure on cognition

The association between hypertensive disorders of pregnancy and subsequent risk of dementia

Researchers evaluate possible mitochondrial factors in Alzheimer's pathogenesis

Diets play a major role in reducing the risk of Alzheimer's disease

New insights into the interplay between prions and TDP-43 in neurodegenerative pathology

Neuroimaging and network modeling tools shed light on Alzheimer's disease in animal models

Study evaluates personality predictors of dementia diagnosis and neuropathology

Study finds top three classes of medications more effective than ibuprofen for treating migraine attacks

Deep brain, multipurpose fiber could revolutionize Alzheimer's research

Study finds link between early coronary heart disease and dementia

Study uncovers mechanisms underlying microglia-driven neuroinflammation in Alzheimer's disease

Personalized lifestyle changes delay memory loss in older adults at risk for Alzheimer's

Dementia patients often receive different treatment after hospital transfer, study finds

Immune receptor protein linked to healthy aging and lifespan in mice

Study shows link between personal wealth and health care costs in people with Alzheimer’s disease

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

Brain inflammation linked to neuropsychiatric symptoms in Alzheimer's

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News